Diagnostics M&A Review
The IVD Integration/Innovation Movement
FIRST QUARTER 2008

Integration and innovation were central themes used to describe transaction activity in the in-vitro diagnostics (“IVD”) industry throughout 2007, and the impact of these factors can be examined on both a tactical and strategic level. Estimates for a shortage of trained laboratory technicians have resulted in greater emphasis being placed on the ability of new products and technologies to incorporate a wide array of diseases, communicate with a large number of data sources and automate routine and/or repetitive tasks. This emphasis has specific goals in 2007 in Review: The IVD Integration/Innovation Movement both clinical and drug development settings: improved laboratory efficiency, faster decision-making, fewer medical errors (in a clinical sense), reduced drug development costs and faster time to market for newly developed drugs.

From a mergers and acquisitions perspective, the need for innovative new products that can be smoothly integrated into existing and anticipated IVD platforms resulted in over 200 transactions in 2007, with several mega-deals changing the competitive landscape of the industry.

Download our complete Diagnostics M&A Review. To subscribe to receive future reports on the diagnostics industry, please complete our online request form.